Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Moodys
Baxter
UBS
Julphar
Covington

Generated: March 26, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for AT7519

« Back to Dashboard

US Patents for AT7519

Glossary
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
AT7519 ➤ Try a Free Trial Low, immune enhancing, dose mtor inhibitors and uses thereof Novartis AG (Basel, CH) ➤ Try a Free Trial
AT7519 ➤ Try a Free Trial 3,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators Astex Therapeutics Limited (Cambridge, GB) ➤ Try a Free Trial
AT7519 ➤ Try a Free Trial 3,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators Astex Therapeutics Limited (Cambridge, GB) The Institute of Cancer Research: Royal Cancer Hospital (London, GB) Cancer Research Technology Limited (London, GB) ➤ Try a Free Trial
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for AT7519

Glossary
Drugname Country Document Number Estimated Expiration Related US Patent
AT7519 Australia 2014348657 2033-11-13 ➤ Try a Free Trial
AT7519 Australia 2017245411 2033-11-13 ➤ Try a Free Trial
AT7519 Canada 2929181 2033-11-13 ➤ Try a Free Trial
Drugname Country Document Number Estimated Expiration Related US Patent

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Cantor Fitzgerald
Healthtrust
Fish and Richardson
Federal Trade Commission
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2019 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
Major Patent Expirations 2019 - 2020
 NCE-1 Generic Application Dates 2019 - 2020
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2019, www.DrugPatentWatch.com.
Links

Follow DrugPatentWatch: